Tianhong Zhu

No. 59 Liuting Street
Ningbo, 315010, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.

Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.

Journal: Cell death discovery
Published: April 14, 2026

CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.

CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.

Journal: Cell death discovery
Published: December 30, 2024

ClC-3 inhibition induces autophagy to reverse cisplatin resistance in cervical cancer via the Akt/mTOR pathway.

ClC-3 inhibition induces autophagy to reverse cisplatin resistance in cervical cancer via the Akt/mTOR pathway.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 03, 2024

Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysis.

Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysis.

Journal: Quantitative imaging in medicine and surgery
Published: October 11, 2024

FTO triggers NLRP3/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer.

FTO triggers NLRP3/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer.

Journal: Cellular signalling
Published: April 23, 2024

Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.

Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.

Journal: Frontiers in endocrinology
Published: April 15, 2024

KDM4A Silencing Reverses Cisplatin Resistance in Ovarian Cancer Cells by Reducing Mitophagy via SNCA Transcriptional Inactivation.

KDM4A Silencing Reverses Cisplatin Resistance in Ovarian Cancer Cells by Reducing Mitophagy via SNCA Transcriptional Inactivation.

Journal: Current molecular medicine
Published: December 11, 2023

TRIM28 recruits E2F1 to regulate CBX8-mediated cell proliferation and tumor metastasis of ovarian cancer.

TRIM28 recruits E2F1 to regulate CBX8-mediated cell proliferation and tumor metastasis of ovarian cancer.

Journal: Human cell
Published: June 09, 2023

Identifying Immune Cell Infiltration and Hub Genes Related to M2 Macrophages in Endometriosis by Bioinformatics Analysis.

Identifying Immune Cell Infiltration and Hub Genes Related to M2 Macrophages in Endometriosis by Bioinformatics Analysis.

Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: November 20, 2022

Is there different prognosis between cervical endometrioid adenocarcinoma and ordinary cervical adenocarcinoma in a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database?

Is there different prognosis between cervical endometrioid adenocarcinoma and ordinary cervical adenocarcinoma in a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database?

Journal: Translational cancer research
Published: March 28, 2022

Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?

Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?

Journal: BMC women's health
Published: March 13, 2018

Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain.

Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain.

Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: September 29, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026